WASHINGTON—The Society for Cardiovascular Angiography & Interventions (SCAI) and Cardiovascular Research Technologies (CRT) today announce a new collaboration to elevate the field of interventional ...
The Society for Cardiovascular Angiography & Interventions (SCAI) and Cardiovascular Research Technologies (CRT) today announce a new collaboration to elevate the field of interventional cardiology ...
Electrophysiologists at the Texas Cardiac Arrhythmia Institute at St. David’s Medical Center in Austin recently became the first in the U.S. to implant an FDA-approved leadless system for cardiac ...
Newer pacing method matched standard cardiac resynchronization therapy with respect to clinical outcomes in the first ...
Please provide your email address to receive an email when new articles are posted on . 4D model-guided cardiac resynchronization lead placement improved left ventricular function vs. standard care.
AMSTERDAM, the Netherlands—Among patients with heart failure with reduced ejection fraction (HFrEF), a previously implanted pacemaker or ICD, and a significant RV pacing burden, upgrading to a cardiac ...
BOSTON -- Early cardiac resynchronization therapy (CRT) benefited patients with moderately reduced ejection fraction (EF) and left bundle branch block (LBBB) but no indication for pacing, according to ...
Please provide your email address to receive an email when new articles are posted on . Long-term CRT-D use was tied to improved survival and time to adverse events vs. ICD therapy in patients with ...
DINAJPUR, April 30, 2026 (BSS) - For the first time in Dinajpur, a Cardiac Resynchronization Therapy (CRT) device has been ...
Leadless pacing within the LV endocardium via the WiSE CRT System (EBR Systems) is a safe and effective option for cardiac resynchronization therapy (CRT), according to results from the SOLVE-CRT ...
GRAPEVINE, TX — Risk stratification of patients with chronic heart failure and a defibrillating cardiac resynchronization therapy (CRT-D) device may be improved by combining natriuretic peptide levels ...
For thrombus inhibition before percutaneous coronary intervention (PCI), a high-dose bolus of tirofiban (Aggrastat) in combination with anticoagulation beat conventional heparin and bivalirudin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results